|
I was at the genetech dinner 2 nights ago and asked one of the company directors about the study and his response was, who would you believe, the national study with thousands of individuals or the Finnish one with a couple hundred? I'm sure that many companies with a socialized health care system will be scrutanizing this study closely and probably designing trials to try to duplicate it but for the time being......
Now as I mentioned before, from a cost-benefit analysis, which I'm sure many of these countries are looking at, the theraputic advantage / difference, will be an issue when weighing the total impact on the National health care system. That said, if further larger studies validate the Finnish study, it will be a true bonus.
Al
__________________
Primary care-giver to and advocate for Linda, who passed away April 27, 2006.
|